VNDA icon

Vanda Pharmaceuticals
VNDA

Overview Fund Activity

116 hedge funds and large institutions have $342M invested in Vanda Pharmaceuticals in 2016 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 37 increasing their positions, 38 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
116
Holders Change
-1
Holders Change %
-0.85%
% of All Funds
3.1%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.11%
New
17
Increased
37
Reduced
38
Closed
18
Calls
$1.72M
Puts
$1.48M
Net Calls
+$246K
Net Calls Change
-$1.73M

Top Buyers

1
Millennium Management
1
Millennium Management
New York
$18.1M
2
GPP
2
Great Point Partners
Connecticut
$22.8M
3
Goldman Sachs
3
Goldman Sachs
New York
$2.62M
4
SCM
4
Stonepine Capital Management
Oregon
$17.3M
5
Macquarie Group
5
Macquarie Group
Australia
$10.3M

Top Sellers

1
CCM
1
Consonance Capital Management
New York
$0
2
KCM
2
Kingdon Capital Management
New York
$3.88M
3
ACA
3
Avoro Capital Advisors
New York
$7.14M
4
Invesco
4
Invesco
Georgia
$0
5
Skandinaviska Enskilda Banken (SEB)
5
Skandinaviska Enskilda Banken (SEB)
Sweden
$1.01M
Name Holding Trade Value Shares
Change 		Shares
Change %
ARTA
126
A.R.T. Advisors
New York
– -$319K -34,352 Closed
DS
127
DRW Securities
Illinois
– -$303K -32,500 Closed
ACP
128
Acuta Capital Partners
California
– -$260K -27,952 Closed
LCM
129
Landscape Capital Management
New Jersey
– -$238K -25,531 Closed
HCM
130
Highbridge Capital Management
New York
– -$162K -17,423 Closed
QT
131
Quantbot Technologies
New York
– -$57K -6,220 Closed
ST
132
Spot Trading
Illinois
– -$1K -107 Closed
2 3 4 5
6